DNA synthesized by particulate fractions from human leukemic white blood cells has been subfractionated by hybridization to Rauscher leukemia virus 70S RNA followed by hydroxylapatite chromatography. The Rauscher-leukemia-virus-specific DNA fraction is shown to be complementary only to sequences present in the nuclear DNA of Balb/c mouse spleens infected by this virus and the nuclear DNA from human leukemic white blood cells, and not to sequences present in the nuclear DNA of normal Balb/c mouse spleens or the nuclear DNA of normal human white blood cells. EDTA, pH 7.4, 0.01 M NaCl, 4% sodium dodecyl sulfate. The fractions eluting in the void region of the column (10 ml) were pooled, brought to 0.4 M NaCl, and the cDNA was precipitated with ethanol as above. The pellet was resus-
RNA tumor viruses have been linked to a number of human neoplastic processes (1, 2) . Evidence associating RNA tumor viruses with human leukemia includes: (1) possible homology between a portion of the Rauscher leukemia virus (RLV) genome and the RNA of human leukemic white blood cells (WBC) (3); (2) identification of a particulate fraction from human leukemic WBC, with the density characteristic of RNA tumor viruses, which can direct the synthesis of DNA that is partially homologous to both RLV and simian sarcoma virus (SSV) RNA (4, 5) ; (3) [3H]DNA synthesized from RLV RNA anneals more extensively to human leukemic WBC nuclear DNA than to human normal WBC nuclear DNA (W. G. Baxt and S. Spiegelman, in preparation).
With [3H]DNA synthesized endogenously by murine RNA tumor viruses, it has recently been demonstrated that part of the RLV and AKR virus genome not detectable in normal murine cells is detectable in RLV-and AKR-induced neoplastic cell nuclear DNA (6, 17) . With complementary [3H]-DNA (cDNA) prepared from human leukemic WBC particulate fractions, it has also been shown that there are DNA sequences in human leukemic WBC that do not appear to be present in normal WBC (7, 8) . However, it has not been shown whether these human leukemia-specific DNA sequences are either: (1) complementary to any part of a known RNA tumor virus genome or (2) identical to RLV or AKR tumorspecific sequences.
It is the purpose of the work described here to anneal human leukemic cDNA to RLV RNA, to reisolate cDNA Abbreviations: RLV, Rauscher The fractions eluting in the void region of the column (10 ml) were pooled, brought to 0.4 M NaCl, and the cDNA was precipitated with ethanol as above. The pellet was resus-pended in 3 mM EDTA, pH 7.4, and stored fat 20 (all nucleic acids were so precipitated and resuspended). Human Leukemic Cytoplasmic RNA. Human leukemic cytoplasmic RNA was prepared by bringing the 40,000 X g supernatant described above to 0.5% sodium dodecyl sulfate and shaking with an equal volume of phenol; this was centrifuged for 10 min at 10,000 X g at 200. The RNA was precipitated by the addition of 2 volumes of 95% ethanol to the aqueous layer and collected by centrifugation at 10,000 X g at -20°for 10 min. The precipitate was resuspended as above, layered on CsCl (density = 1.84 g/ml) and pelleted by centrifugation in a Beckman 50 Ti rotor at 44,000 rpm at 200 for 60 hr. The pellet was resuspended in 3 mM EDTA, 0.4 M NaCl, pH 7.4, and precipitated with ethanol (without carrier yeast RNA) and resuspended as above. The RNA banded in Cs2SO4 gradients at a density of 1.65 g/ml.
RLV 70S RNA. Plasma from RLV-infected Balb/c mice was centrifuged at 3000 rpm at 100 for 10 min. Preparation of Nuclear DNA. A nuclear (and membrane) pellet (obtained from opening normal human WBC or leukemic WBC with a Dounce homogenizer or by homogenizing 5 g of either Balb/c or RLV-infected Balb/c mouse spleen in TNE and then opening the cells with a Dounce homogenizer, followed by centrifugation at 3000 X g for 15 min at 20) was resuspended in TNE and lysed by bringing the solution to 1% sodium dodecyl sulfate in 1 M NaClO4. After repeated extraction with chloroform-isoamyl alcohol (96:4 v:v) the DNA was precipitated with alcohol and spooled out of solution. The DNA was redissolved in 5 mM NaOH buffer and sonicated to 6-8 S (as measured in an alkaline 10-30% glycerol gradient) with a Bronwill Biosonic IV sonifier using the microtip at maximum power for two 30-sec intervals. The sample was then incubated with 0.3 M NaOH for 2 hr at 370. After neutralization with 0.04 M HCl and TE buffer (0.01 M TrisHCl, pH 8.2, 3 mM EDTA) at 20, DNA was precipitated with ethanol, resuspended as above in TE buffer and dialyzed against TE buffer for 36 hr.
-Annealing Conditions. Annealing reaction mixtures contained 0.1 ,ug-1.5 mg of cellular DNA or RNA, and 3 pg-1 ng of cDNA in a final volume of 0.05 ml. The mixture was brought to 980 for 60 sec and 0.04 mmole of NaCl was added. The reaction mixture was then incubated at 500 (RNA * DNA) or 60°(DNA -DNA), for 20 hr. Each sample was diluted by and then applied to a column of hydroxylapatite of 10-ml bed volume (this provides at least 100,gg of double-stranded DNA per ml of wet packed hydroxylapatite) at 500 (RNA. DNA) or 600 (DNA-DNA). The column was washed with successive 25-ml portions of 0.15 M (P) phosphate buffer, pH 6.8, at 500, 600, 800 and 980 Four-milliliter fractions were collected and the A260 of each (DNA-DNA reactions only) was read. Each sample was then adjusted to 2 Ag/ml of carrier yeast RNA and precipitated with 10% trichloroacetic acid and its radioactivity was measured.
Isolation of Slowly Annealing cDNA. cDNA (0.01 Mg) was reacted with leukemic WBC RNA to a Crt (11) of 10 at 500; approximately 8-12% of the DNA anneals to the RNA (W. G. Baxt, D. Kohne, and S. Spiegelman, in preparation). The sample was passed over a hydroxylapatite column at 500, and the material not absorbing to the hydroxylapatite was eluted by washing the column with 0.15 M (P) phosphate buffer, pH 6.8. The eluted single-stranded slowly annealing cDNA was pooled and alkali treated, neutralized, passed over Sephadex G-50, ethanol precipitated and resuspended as above.
Isolation of Leukemic cDNA Homologous to RLV 70S RNA. Six nanograms of nonrepeat leukemic cDNA was reacted with 10 jg of RLV 70S RNA as above for 24 hr at 500. This was then passed over hydroxylapatite at 500 and the column washed with 50 ml of 0.15 M (P) phosphate buffer, pH 6.8. The column was then washed with 10 ml of 0.15 M (P) phosphate buffer, pH 6.8, at 800. The cDNA still adsorbed to the column was recovered by washing the column with 0.15 M (P) phosphate buffer, pH 6.8, at 1000. The 70S RNA, while <1% was shifted by AMV 70S RNA, confirming the specificity of the isolated human probe for the RLV sequences.
The cDNA homologous to RLV RNA was then hybridized extensively (Cot = 5 X 105) to both uninfected and RLVinfected Balb/c mouse spleen nuclear DNA; the results of AMV-RNA . Hybridizations were done as outlined in Materials and Methods.
Input nuclear DNA was 2.5 mg, cDNA was 5 pg. Incubation was at 600 for 24 hr. Assay: hydroxylapatite. Only duplexes eluting at temperatures >80°were scored. Background was 6 cpm.
this experiment are summarized in Table 1 . Ninety-two to 95% of the cDNA reacted with the infected spleen DNA, while there was no detectable reaction with the uninfected spleen DNA, suggesting that the human leukemic cDNA homologous to RLV RNA represents part of the RLV genome that is murine leukemia specific. Ninety percent of the cellular DNA in these experiments had annealed at the time of assay, as measured by A260.
The human leukemic cDNA complementary to RLV RNA was reacted with human normal and leukemic WBC nuclear DNA. Fig. 5 is a composite Cot curve obtained from three such hybridizations. The cDNA annealed as a nonrepeated sequence (11) with leukemic WBC nuclear DNA to an extent of 96% but did not react with normal WBC DNA. This paralleled the data obtained in the murine system and implies again that the nonrepeated human sequences homologous to part of the RLV genome are unique to the leukemic nucleus. The Cot curve of the cellular DNA in these experiments as followed by A260 was as previously reported (11) . It must be pointed out that these data do not imply that all the cDNA that initially anneals to RLV 70S RNA is homologous to the RLV RNA. Under the conditions used here, the hydrogen bonding of only 40 to 50 base pairs would be necessary to yield a duplex stable at temperatures >800. Since the DNA used in these experiments migrates in the 4S region of alkaline sucrose sedimentation velocity gradients (unpublished results), it is approximately 150 nucleotides (estimated). In view of this, only 30% of the probe need be homologous to the RLV RNA to be reisolated by the procedures used here. It is thus possible that the portion(s) of the probe annealing to the human leukemic nuclear DNA may represent sequences present in the 70% of the probe that is in fact not necessarily homologous to RLV RNA. Because of this, it is not possible to say that the sequences that are RLV-specific and human leukemic-specific are, in fact, absolutely identical.
DISCUSSION
With human leukemic cDNA as a probe, it has recently been demonstrated that there are sequences present in the nuclear DNA of leukemic WBC that are not detectable in normal WBC (7, 8) . Although the sequences unique to leukemic nuclear DNA were detected by a probe made from a leukemic WBC extract potentially enriched for RNA tumor virus-like particles, there was and has been no direct evidence that linked these sequences specifically with an actual RNA tumor virus.
It is clear that RLV causes erythroblastic leukemia in Balb/c mice (12) . Even though Balb/c cells may possess the genetic information specifying for possibly two endogenous RNA tumor viruses (13, 14) , the tumorogenic potential of these viruses may be absent or low. The endogenous virus genes may be missing that information capable of inducing cell transformation that is present in the RLV genome. This may be the new RLV-related information detectable in Babl/c leukemic cells after RLV-induced leukemia (17) . The data presented here demonstrate that cDNA synthesized from human leukemic WBC extracts that is highly complementary (melting temperature of the hybrid DNA, Tm >800) to part of the murine RLV genome is: (1) represented only the nuclear DNA of RLV-induced leukemic murine cells but not in the DNA of normal murine cells, and (2) represented only in the nuclear DNA of human leukemic WBC but not in that of human normal WBC. In both the murine and human leukemias, nuclear information is detectable that is specific to the oncogenic state and complementary to part of the genome of the agent known to cause the murine neoplasia.
The fact that the genetic information of a murine RNA tumor virus is complementary to human neoplastic DNA has always been surprising, but recent work (15, 16) indicates a high degree of homology between the murine RNA tumor virus genome and the primate RNA tumor virus genome, while there is little other interspecies viral homology (15, 16) . The choice of RLV in these and other studies (3) (4) (5) There are two major areas of contention in this study. The first is that the qualitative differences demonstrated in these data between normal and leukemic WBC nuclear DNA may be artifactual. The control DNA in these experiments may be inadequate in that it is extracted from a nonreplicating cell, whereas leukemic cell DNA is extracted from a replicating cell. The consequences of replication could be alterations in nuclear DNA: (1) The second point of contention is that the genomic differences detected between normal and leukemic WBC nuclear DNA may be etiologically irrelevant to leukemia. (1) The information shared by RLV and leukemic WBC may represent nonspecific information unrelated to both viral and leukemic functions. (2) Human leukemic patients are known to be highly susceptible to superinfection by virtually any organism, and these data may simply reflect superinfection by an RNA-tumor-virus-like agent, but as a result of neoplasia and not as a cause of it.
